Magnolia Capital Advisors LLC Has $1.93 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Magnolia Capital Advisors LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 110.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,806 shares of the healthcare conglomerate’s stock after buying an additional 1,995 shares during the period. UnitedHealth Group makes up 1.0% of Magnolia Capital Advisors LLC’s portfolio, making the stock its 21st largest position. Magnolia Capital Advisors LLC’s holdings in UnitedHealth Group were worth $1,925,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the 3rd quarter valued at $27,000. West Financial Advisors LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at $32,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth about $37,000. Finally, Quarry LP raised its holdings in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 0.6 %

NYSE UNH opened at $542.30 on Monday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company’s 50-day moving average price is $536.17 and its 200-day moving average price is $565.26. The stock has a market cap of $499.07 billion, a PE ratio of 34.99, a PEG ratio of 1.48 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the firm posted $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is 54.19%.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $629.32.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.